Kajian klinikal COPD di Dallas, TX
12 kajian untuk COPD sedang mencari peserta di lokasi dalam dan sekitar Dallas (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Mengambil pesertaFasa 3
- Research Site, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Mengambil pesertaFasa 3
- IntraCare- Site Number : 8400034, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Mengambil pesertaFasa 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Mengambil peserta
- University of Texas Southwestern, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Mengambil pesertaFasa 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Mengambil pesertaFasa 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Mengambil pesertaFasa 2/3
- Alina Clinical Trials, LLC., Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Mengambil pesertaFasa 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
Mengambil pesertaKajian pemerhatian
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Mengambil pesertaFasa 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Mengambil pesertaFasa 3
- GSK Investigational Site, Dallas
Kajian COPD di bandar lain
- Philadelphia, PA23 kajian
- Miami, FL18 kajian
- Birmingham, AL17 kajian
- Boston, MA17 kajian
- Houston, TX15 kajian
- Orlando, FL15 kajian
- Baltimore, MD14 kajian
- Chicago, IL14 kajian
- Pittsburgh, PA12 kajian
- New York City, NY11 kajian
- Ann Arbor, MI10 kajian
- Winston-Salem, NC9 kajian
Kajian lain di Dallas
- Kanser Payudara55 kajian
- Kanser Paru-paru Bukan Sel Kecil52 kajian
- Kanser Metastatik42 kajian
- Kegagalan Jantung42 kajian
- Kanser (semua jenis)37 kajian
- Kanser Prostat36 kajian
- Kanser Kolorektal33 kajian
- Obesiti30 kajian
- Kanser Ovari28 kajian
- Kanser Pundi Kencing27 kajian
- Kanser Paru-paru27 kajian
- Kanser Endometrium24 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.